Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Association between prior somatic disease and 5-year relapse risk among 11,856 incident patients with schizophrenia

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated With SARS-CoV-2 Infection

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. The Duffy-null genotype and risk of infection

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Detection of illness worry in the general population: A specific item on illness rumination improves the Whiteley Index

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: Somatic diseases have been associated with an increased risk for subsequent schizophrenia; however, it is unknown whether prior somatic diseases negatively affect early treatment outcomes after a first-time schizophrenia diagnosis. Methods: We included all individuals born in Denmark after January 1 st , 1977 and first-time diagnosed with schizophrenia between January 1 st , 1996 and December 31 st , 2015. We identified all life-time somatic hospital contacts and all prescriptions within the year before the first-time schizophrenia diagnosis and followed patients for up to five years regarding risk for schizophrenia (re)-hospitalization (relapse). We performed Cox regression analyses calculating hazard rate ratios (HRR) including 95%-confidence intervals (CI) and adjusted for relevant confounders. Results: We followed a total of 11,856 patients with a first-time schizophrenia diagnosis (58.7% male, mean age 23.1 (SD = 4.7) years) for 39,033 person-years, whereof 5506 (46.4%) had relapse with schizophrenia re-hospitalization during 5-year of follow-up. Somatic hospital contacts ever before (95.4%; HRR = 1.30; 95%-CI = 1.07–1.59), and specifically during the year before schizophrenia diagnosis (42.5%; HRR = 1.36; 95%-CI = 1.11–1.66) were associated with an increased risk of schizophrenia relapse as were a greater number of prior somatic hospital contacts (p < 0.001). Individuals with up to four different prescriptions for somatic medications showed a trend towards a slightly lower risk of relapse. Conclusion: Somatic diseases and health seeking patterns might have an impact on the course of schizophrenia, where severe somatic comorbidity, specifically during the year before first-time schizophrenia diagnosis, seem to negatively affect early treatment course, whereas previous somatic medication use may indicate a better compliance and help-seeking behavior.

Original languageEnglish
JournalEuropean psychiatry : the journal of the Association of European Psychiatrists
Pages (from-to)1-7
Number of pages7
Publication statusPublished - Jun 2019

    Research areas

  • Early intervention, Early onset schizophrenia, Epidemiology, Register-based, Relapse, Schizophrenia, Somatic comorbidity, Somatic diseases

ID: 57461400